[vc_row][vc_column][vc_column_text css_animation=”top-to-bottom”]

Fortune 500 Pharmaceutical Company Legacy Real Estate Asset Closure and Divestiture Strategy (client confidential)

[/vc_column_text][vc_separator border_width=”3″][vc_row_inner][vc_column_inner width=”1/3″][vc_single_image image=”5780″ img_size=”full”][/vc_column_inner][vc_column_inner width=”2/3″][vc_column_text]Project
Fortune 500 Pharmaceutical Company Legacy Real Estate Asset Closure and Divestiture Strategy (client confidential)

Project Description
Financial restructure and divestiture analysis of a large tract R&D facility

Project Background
Asset and liability assessment, quantification, monetization, and mitigation analysis, including environmental remediation and demolition liability

Business Plan
Market feasibility study, highest and best use analysis and development of a TOD-oriented master plan for mixed use residential, retail, and office use/reuse.

The RESIGHT Solution
Identification and financial analysis of a range of divestiture/reuse options including like-kind sale, “as is, where is” sale, mixed use residential/commercial sale/leaseback and long-term custodial care[/vc_column_text][vc_column_text][ssbp][/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]